asoxime chloride has been researched along with Abnormalities, Autosome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berend, S; Fuchs, N; Kopjar, N; Radić, B; Vrdoljak, AL; Zeljezić, D | 1 |
| Bigger, CA; Jacobson-Kram, D; Levine, BS; Putman, D; San, RH | 1 |
2 other study(ies) available for asoxime chloride and Abnormalities, Autosome
| Article | Year |
|---|---|
Evaluation of HI-6 oxime: potential use in protection of human acetylcholinesterase inhibited by antineoplastic drug irinotecan and its cyto/genotoxicity in vitro.
Topics: Acetylcholinesterase; Adult; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Cells, Cultured; Cholinesterase Inhibitors; Chromosome Aberrations; Female; Humans; Irinotecan; Lymphocytes; Molecular Structure; Oximes; Pyridinium Compounds | 2007 |
Genetic toxicology assessment of HI-6 dichloride.
Topics: Analysis of Variance; Animals; Bone Marrow; Cells, Cultured; CHO Cells; Cholinesterase Reactivators; Chromosome Aberrations; Cloning, Molecular; Cricetinae; Dose-Response Relationship, Drug; Female; Humans; Liver; Lymphocytes; Lymphoma; Male; Metaphase; Mice; Mutagenicity Tests; Mutagens; Mutation; Oximes; Pyridinium Compounds; Rats; Rats, Sprague-Dawley; Risk Assessment | 1996 |